Ye, Gang
Li, Zhe
Yue, Yan
Wu, Yuxuan
Yang, Ruchang
Wang, Haitao
Wu, Siqi
Zhou, Yue
Zhao, Xueli
Lv, Xiaoli
Yuan, Nian
Li, Ronghua
Zhang, Guangya
Ganapathi, Pallavi B.
Wu, Hanjing Emily
Du, Xiangdong
Zhang, Xiang-Yang
Funding for this research was provided by:
Suzhou Gusu Health Talents Scientific Research Project (GSWS2020097, GSWS2021053)
Jiangsu Province "333 Project" scientific research project (BRA2020120)
Key Diagnosis and treatment Program of Suzhou (LCZX202016)
The Suzhou clinical Medical Center for mood disorders (Szlcyxzx202109)
Suzhou Clinical Expert Team Introduced Project (SZYJTD201715)
Article History
Received: 18 May 2022
Accepted: 6 September 2022
First Online: 16 September 2022
Declarations
:
: This study was conducted at the psychiatric clinic department in a general hospital in Taiyuan, Shanxi province, China. The protocol and informed consent of this study was approved by the Institutional Review Board, the First Clinical Medical College, Shanxi Medical University (No. 2016-Y27). Following a complete description of the study protocol and procedures to each participant by a psychiatrist or research coordinator, then written informed consent was obtained. All methods were carried out in accordance with the Declaration of Helsinki promulgated by the National Institute of Health.
: Not applicable.
: The authors declare no conflict of interest.